Sigma records 41% EBIT growth in FY25
SIGMA recorded normalised EBIT growth of 41% and statutory net profit after tax of $529.9 million in its first post-merger…
Painkiller link with AMR
IN THE first study of its kind, Australian researchers have discovered that ibuprofen and paracetamol could be driving antimicrobial resistance…
Presolol 100 SSSI
THE Therapeutic Goods Administration (TGA) has been advised by Alphapharm that its Presolol 100 (labetalol hydrochloride 100mg) tablets, used to…
Call for expanded vaccination access
GENERAL practitioners are calling on the New South Wales Government to urgently expand free vaccination access state-wide, including an upcoming…
Allergy rates rise
MORE than eight million Australians (30%) now live with allergic disease, up from 4.1 million (19.6%) in 2007, according to…
Crampeze: effective multi-combination solution vs magnesium alone for cramp relief
CRAMPEZE combines Viburnum Opulus (cramp bark), magnesium and a unique combination of ingredients. It is an effective multi-combination product versus…
PD for Wed 27 Aug 2025
Sigma records 41% EBIT growth for FY25, painkiller link with AMR, new allergy report reveals rising rates and costs, and…
PD breaking news – Sigma records 41% EBIT growth in FY25 results
Sigma recorded normalised EBIT growth of 41% in its first post-merger end-of-year results. Key figures include like-for-like sales growth of…
APC public consultation EOI
THE Australian Pharmacy Council (APC) has announced that the expression of interest (EOI) to participate in the public consultation forums…
Board guidelines consultation
THE Pharmacy Board of Australia has released draft Guidelines for pharmacists on the safe provision of pharmacy services including medicines…